Eric Bjerkholt, Chief Financial Officer at Aimmune Therapeutics, Inc. (AIMT), bought 1,000 shares at $15.10 ($15K) on 2020-03-12, disclosed to the SEC on 2020-03-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MIRM | SELL | 2026-07-08 | $611K | — | Filing → |
| CERS | SELL | 2026-06-11 | $53K | — | Filing → |
| MIRM | SELL | 2026-06-09 | $469K | — | Filing → |